Received Mar 25, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
I'm allergic; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of allergy in a patient who received Herpes zoster (Shingrix) for prophylaxis. In 2026, the patient received Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced allergy (Verbatim: I'm allergic). The outcome of the allergy was unknown. It was unknown if the reporter considered the allergy to be related to Shingrix. It was unknown if the company considered the allergy to be related to Shingrix. Additional Information: GSK Receipt Date: 02-MAR-2026 This case was reported by a patient via interactive digital media. The patient was allergic. The batch number was not provided, and we are unable to contact the reporter.